Italy Vaccines Market Size & Outlook, 2025-2033

Italy Vaccines Market Insights

Based on Reed Intelligence findings, the Italy Vaccines Market reached USD 2091.84 Million in 2024 and is estimated to attain USD 3795.93 Million by 2033.
From 2025 to 2033, the Italy market is expected to grow at a steady CAGR of 6.79%.
Within the By Type category, Monovalent dominated in 2024 in terms of market size contribution.
Over the forecast period, Monovalent is forecasted to deliver the fastest growth, positioning it as the most lucrative By Type segment.

Other Key Findings

Italy contributed 3.1% to the global Vaccines Market size in 2024.
By 2033, United States is forecasted to remain the largest global market for Vaccines Market.
In Europe, Germany is projected to capture the leading share of market size by 2033.
Among Europe markets, Germany is expected to post the fastest growth, reaching USD 8977.92 Million by 2033.

Report Summary

Report Scope	Details
Base Year for Study	2024
Study Period	2021-2033
Historical Period	2021-2023
Forecast Period	2025-2033
Market Size In 2024	USD 2091.84 Million
Market Size In 2033	USD 3795.93 Million
Largest segment	Monovalent
Units	Revenue in USD Million
CAGR	6.79% (2025-2033)
Segmnetation Covered
By Type	Monovalent Multivalent
By Route of Administration	Oral Parenteral Nasal
By Disease Indication	Viral Bacterial
By Age Group	Pediatric Adult
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Italy Vaccines Market By Type 2025-2033 (USD Million)

By Type	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Monovalent	XX.x	XX.x	XX.x	1312.42	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Multivalent	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Italy Vaccines Market By Route of Administration 2025-2033 (USD Million)

By Route of Administration	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Oral	XX.x	XX.x	XX.x	1110.56	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Parenteral	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Nasal	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Italy Vaccines Market By Disease Indication 2025-2033 (USD Million)

By Disease Indication	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Viral	XX.x	XX.x	XX.x	1310.12	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Bacterial	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Italy Vaccines Market By Age Group 2025-2033 (USD Million)

By Age Group	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Pediatric	XX.x	XX.x	XX.x	1223.73	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Adult	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Author :

Reed Intelligence Research Team

The Reed Intelligence Research Team brings together over 15+ years of collective experience in market research, data analytics, and strategic consulting. Comprising seasoned analysts, economists, and industry specialists, the team delivers precise, data-driven insights across sectors including technology, healthcare, energy, manufacturing, and consumer goods. By combining domain expertise with modern analytical tools, they ensure each report meets the highest standards of accuracy and relevance.